Iskandarani, Ahmad N.; Bhat, Ajaz Ahmad; Siveen, Kodappully Sivaraman; Prabhu, Kirti S.; Kuttikrishnan, Shilpa; Khan, Muzammil Ahmad; Krishnankutty, Roopesh; Kuliński, Michał; Nasr, Rihab R.; Mohammad, Ramzi M.; Uddin, Shahab
(BioMed Central Ltd., 2016)
Background: Proteasome inhibitors are attractive cancer therapeutic agents because they can regulate apoptosis-related proteins. Bortezomib also known as Velcade®, a proteasome inhibitor that has been approved by the food ...